Joel S. Schuman, MD, FACS, highlights home tonometry, virtual visual fields, and portable OCT devices as promising tools, ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and ...

Glaucoma, the silent thief of sight, damages the optic nerve without early symptoms, leading to irreversible vision loss.

In matched cohorts of more than 41,000 patients each, use of tirzepatide was linked to a significantly reduced risk of primary open-angle glaucoma compared with selective GLP-1 receptor agonists (risk ...

Laser eye surgeries can help treat glaucoma by improving the outflow of fluid in the eye. Types of surgeries include trabeculoplasty, iridotomy, and cyclophotocoagulation. Doctors may suggest a ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual fundraising challenge with Glaucoma ...

Faster thinning of cpRNFL and mGCIPL is associated with visual field progression in glaucoma, with rates of –1.02 and –1.04 ...

Eating leafy green vegetables is “consistently associated with” a lower risk for developing primary open-angle glaucoma, ...

Although there already are "smart" contact lenses that monitor the eyes for signs of glaucoma, the devices are typically only worn when the patient is awake. A new type of contact lens, however, ...

Doctors may recommend eye drops, oral medications, laser treatment, or surgery for glaucoma. These interventions can help reduce eye pressure and protect the optic nerve from further damage. However, ...

Use of calcium channel blockers (CCBs), particularly cardioselective agents, had a modest but statistically significant association with glaucoma, a large meta-analysis showed. Overall, patients with ...